FINWIRES · TerminalLIVE
FINWIRES

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

By

Moderna (MRNA) has an average rating of hold and mean price target of $96.47, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)

Related Articles